<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1A4928A2-632C-49AF-AA0F-66E902DFC05C"><gtr:id>1A4928A2-632C-49AF-AA0F-66E902DFC05C</gtr:id><gtr:name>Oswaldo Cruz Foundation (Fiocruz)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0BACE25-B55C-4EDF-B5EF-2E48E933C631"><gtr:id>A0BACE25-B55C-4EDF-B5EF-2E48E933C631</gtr:id><gtr:name>University of Tartu</gtr:name><gtr:address><gtr:line1>Ulikooli 18</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Estonia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/47F6CC46-C62F-47B3-9403-695B61E99D92"><gtr:id>47F6CC46-C62F-47B3-9403-695B61E99D92</gtr:id><gtr:name>Istituto Zooprofilattico Sperimentale delle Regioni Lazio e Toscana</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F4DC8F58-AC06-4EB1-976C-EAA0136CC12F"><gtr:id>F4DC8F58-AC06-4EB1-976C-EAA0136CC12F</gtr:id><gtr:name>Museu da Lourinh?</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68F78F03-B2B0-4B8E-AB8D-02362018AD72"><gtr:id>68F78F03-B2B0-4B8E-AB8D-02362018AD72</gtr:id><gtr:name>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8A66BFC9-B9A5-48C6-B46C-761D1C13C5DC"><gtr:id>8A66BFC9-B9A5-48C6-B46C-761D1C13C5DC</gtr:id><gtr:name>Lancaster University</gtr:name><gtr:address><gtr:line1>,</gtr:line1><gtr:region>North West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/22748C58-39CF-4110-8F6C-B0D1D5DF85F3"><gtr:id>22748C58-39CF-4110-8F6C-B0D1D5DF85F3</gtr:id><gtr:name>?cole normale sup?rieure de Lyon (ENS Lyon)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1A4928A2-632C-49AF-AA0F-66E902DFC05C"><gtr:id>1A4928A2-632C-49AF-AA0F-66E902DFC05C</gtr:id><gtr:name>Oswaldo Cruz Foundation (Fiocruz)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0BACE25-B55C-4EDF-B5EF-2E48E933C631"><gtr:id>A0BACE25-B55C-4EDF-B5EF-2E48E933C631</gtr:id><gtr:name>University of Tartu</gtr:name><gtr:address><gtr:line1>Ulikooli 18</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Estonia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/47F6CC46-C62F-47B3-9403-695B61E99D92"><gtr:id>47F6CC46-C62F-47B3-9403-695B61E99D92</gtr:id><gtr:name>Istituto Zooprofilattico Sperimentale delle Regioni Lazio e Toscana</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F4DC8F58-AC06-4EB1-976C-EAA0136CC12F"><gtr:id>F4DC8F58-AC06-4EB1-976C-EAA0136CC12F</gtr:id><gtr:name>Museu da Lourinh?</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68F78F03-B2B0-4B8E-AB8D-02362018AD72"><gtr:id>68F78F03-B2B0-4B8E-AB8D-02362018AD72</gtr:id><gtr:name>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8A66BFC9-B9A5-48C6-B46C-761D1C13C5DC"><gtr:id>8A66BFC9-B9A5-48C6-B46C-761D1C13C5DC</gtr:id><gtr:name>Lancaster University</gtr:name><gtr:address><gtr:line1>,</gtr:line1><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/22748C58-39CF-4110-8F6C-B0D1D5DF85F3"><gtr:id>22748C58-39CF-4110-8F6C-B0D1D5DF85F3</gtr:id><gtr:name>?cole normale sup?rieure de Lyon (ENS Lyon)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CB18B11D-5FF0-498E-8676-369C54B769BF"><gtr:id>CB18B11D-5FF0-498E-8676-369C54B769BF</gtr:id><gtr:firstName>Emma</gtr:firstName><gtr:surname>Thomson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/19E4AE9B-89A4-4CE2-A192-696DDCC93D9E"><gtr:id>19E4AE9B-89A4-4CE2-A192-696DDCC93D9E</gtr:id><gtr:firstName>Alain</gtr:firstName><gtr:surname>Kohl</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UU_12014%2F8"><gtr:id>4846BEB5-B571-4427-B39C-E38C94B91C2D</gtr:id><gtr:title>Arthropod-borne infections and emerging virus infections in high risk areas</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UU_12014/8</gtr:grantReference><gtr:abstractText>Dr Alain Kohl and Dr Emma Thomson, Lead Investigators, Dr Emilie Pondeville and Prof Massimo Palmarini as Collaborators, MRC-University of Glasgow Centre for Virus Research (CVR), University of Glasgow.
Urbanisation, agricultural practices, mass transportation and changing interactions between humans and their environment create unprecedented opportunities for viruses to emerge and spread globally among human populations. Many emerging viruses are transmitted to vertebrate hosts, including humans by arthropod vectors, such as mosquitoes. ?Arboviruses? can replicate in both vertebrates and arthropods and thus overcome a diverse array of hostile antiviral responses from the mosquitoes and the mammalian hosts. In this programme we aim to understand the fundamental processes governing the immune responses of mosquitoes to arboviruses. These studies will increase our understanding of vector ?competence? (i.e. the ability of insect vectors to transmit certain arboviruses) and facilitate the development of novel control measures. Studies on arboviruses and other emerging viruses will also be conducted in collaboration with the Uganda Virus Research Institute in Uganda, where several emergent viruses with epidemic potential have been identified in the past. We aim to identify viruses and other pathogens causing febrile illness in the human population living in 3 geographically distinct regions of Uganda (North West, Central and South West districts).</gtr:abstractText><gtr:technicalSummary>Urbanisation, agricultural practices, mass transportation and changing interactions between humans and their environment create unprecedentend opportunities for viruses to emerge and spread globally among human populations. Many emerging viruses are transmitted to vertebrate hosts, including humans by arthropod vectors, such as mosquitoes. ?Arboviruses? can replicate in both vertebrates and arthropods and thus overcome a diverse array of hostile antiviral responses from species in very different taxa. Our understanding of the antiviral responses in vertebrates far exceeds that of arthropod vectors such as the mosquito Ae. aegypti. Studies on the fundamental processes governing insect vector immune responses to arboviral infections will increase our understanding of vector ?competence? (i.e. the ability of insect vectors to transmit certain arboviruses) and facilitate the development of novel control measures. We will focus on the identification and characterisation of interaction partners of proteins involved in two key RNAi pathways: the exogenous small interfering (si) RNA and PIWI-interacting (pi)RNA pathways. These studies will use viruses like Zika and Chikungunya and the roles and effects of these RNAi pathways and interaction partners will be further analysed in vivo at insect vector tissue and organism level.
Studies on arboviruses and other emerging viruses will also be conducted in collaboration with the Uganda Virus Research Institute in Uganda, where several emergent viruses with epidemic potential have been identified (including yellow fever, Zika, Semliki Forrest, Ebola and Marburg viruses). We aim to identify viruses and other pathogens causing febrile illness in 3 geographically distinct regions of Uganda (North West, Central and South West districts). Specifically, we will study samples from the Acute Febrile Illness cohort (AFI) ? a large UVRI/CDC cohort of patients presenting to health centres with fever, of which 17% remained undiagnosed despite comprehensive diagnostic testing.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-05-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2762000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Istituto Zooprofilattico Sperimentale delle Regioni Lazio e Toscana</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>RiftVectors EMIDA-ERA NET consortium</gtr:description><gtr:id>ED3BB8EF-6939-465C-B4DF-B4901853871C</gtr:id><gtr:impact>1 review published:
http://vir.sgmjournals.org/content/95/Pt_3/517.full.pdf
More publications are planned.</gtr:impact><gtr:outcomeId>sTfLuxCVrY8-3</gtr:outcomeId><gtr:partnerContribution>We interact on several the work packages, and CVR/Kohl leads one of the work packages.</gtr:partnerContribution><gtr:piContribution>Kohl leads the the RiftVectors consortium, which studies the vectors of Rift Valley fever. This includes partners in the UK, France and Italy. subcontractors are located in Italy and Senegal. Associated partners of the RiftVectors consortium are based in Germany and the UK.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Museu da Lourinh?</gtr:collaboratingOrganisation><gtr:country>Portugal, Portuguese Republic</gtr:country><gtr:department>Gulbenkian Institute of Science</gtr:department><gtr:description>Wolbachia Wellcome Trust Project Grant</gtr:description><gtr:id>30C2E6D7-4C99-4029-82CF-2F70E162250E</gtr:id><gtr:impact>Papers currently being written.</gtr:impact><gtr:outcomeId>54521bda7742b2.76944552-2</gtr:outcomeId><gtr:partnerContribution>We have responsibility for one part of the research project. One post-doctoral fellow is employed on the grant.</gtr:partnerContribution><gtr:piContribution>We are co-invstigators on a Wellcome Trust grant financing research at CVR, University of Cambridge and Gulbenkian Institute for Science.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>?cole normale sup?rieure de Lyon (ENS Lyon)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Zika-virus host interactions: evolution and persistence.</gtr:description><gtr:id>4A259B67-8A92-4CA5-9555-517F68177A7F</gtr:id><gtr:impact>Nothing yet.</gtr:impact><gtr:outcomeId>5899f3cd3fe165.62852202-1</gtr:outcomeId><gtr:partnerContribution>Testing of specific aspects of Zika virus evolution.</gtr:partnerContribution><gtr:piContribution>Exchange of reagents and data that relate to evolution and genome characteristics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Wolbachia Wellcome Trust Project Grant</gtr:description><gtr:id>B2BCA14B-DCB9-4375-B5FC-93E354F66AA9</gtr:id><gtr:impact>Papers currently being written.</gtr:impact><gtr:outcomeId>54521bda7742b2.76944552-1</gtr:outcomeId><gtr:partnerContribution>We have responsibility for one part of the research project. One post-doctoral fellow is employed on the grant.</gtr:partnerContribution><gtr:piContribution>We are co-invstigators on a Wellcome Trust grant financing research at CVR, University of Cambridge and Gulbenkian Institute for Science.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Tartu</gtr:collaboratingOrganisation><gtr:country>Estonia, Republic of</gtr:country><gtr:description>ICRES Consortium</gtr:description><gtr:id>780A7057-8BBF-4B45-9E83-FF3ECF0F3ADE</gtr:id><gtr:impact>http://www.plosntds.org/article/info%3Adoi%2F10.1371%2Fjournal.pntd.0002994</gtr:impact><gtr:outcomeId>jPXfYpTqCY8-1</gtr:outcomeId><gtr:partnerContribution>We obtain reagents from collaborators.</gtr:partnerContribution><gtr:piContribution>We have joined this EU FP7 -funded network on chikungunya virus research. Our contribution consists of studies on chikungunya virus-insect cell interactions.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oswaldo Cruz Foundation (Fiocruz)</gtr:collaboratingOrganisation><gtr:country>Brazil, Federative Republic of</gtr:country><gtr:description>MRC-Confap Newton Fund</gtr:description><gtr:id>DEBF4CA3-F73B-4BD4-9F3F-D7FF2B05EB4A</gtr:id><gtr:impact>Current key output: Support of several projects in the UK and elsewhere as part of various initiatives including by MRC and EC on Zika virus.</gtr:impact><gtr:outcomeId>56bf6d30be9623.80412947-1</gtr:outcomeId><gtr:partnerContribution>Provision of virus strains and other material; development of diagnostic tools and patient cohorts for further study.</gtr:partnerContribution><gtr:piContribution>Collaboration on Zika virus; development of diagnostics and patient cohort studies in Brazil with support from CVR; development of genetic tools to study Zika virus and virus host interactions to be carried out at CVR.

Value to CVR: &amp;pound;221,947.97</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Pirbright Institute</gtr:department><gtr:description>Engineering of arboviruses for studies in insect cells</gtr:description><gtr:id>5DD62633-1187-4A46-B0F5-8022FD81855F</gtr:id><gtr:impact>One paper published (PMID: 23559478) . We expect at least one more publication in 2014.</gtr:impact><gtr:outcomeId>DE4BS7Y9kQx-1</gtr:outcomeId><gtr:partnerContribution>Experimental assays.</gtr:partnerContribution><gtr:piContribution>We collaborate on engineering alphavirus and bunyavirus genomes for studies in insect cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lancaster University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>RiftVectors EMIDA-ERA NET consortium</gtr:description><gtr:id>CDDCA504-E6E2-435F-B860-597900D25915</gtr:id><gtr:impact>1 review published:
http://vir.sgmjournals.org/content/95/Pt_3/517.full.pdf
More publications are planned.</gtr:impact><gtr:outcomeId>sTfLuxCVrY8-2</gtr:outcomeId><gtr:partnerContribution>We interact on several the work packages, and CVR/Kohl leads one of the work packages.</gtr:partnerContribution><gtr:piContribution>Kohl leads the the RiftVectors consortium, which studies the vectors of Rift Valley fever. This includes partners in the UK, France and Italy. subcontractors are located in Italy and Senegal. Associated partners of the RiftVectors consortium are based in Germany and the UK.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>RiftVectors EMIDA-ERA NET consortium</gtr:description><gtr:id>93E02C16-C623-4E1D-BB09-1E8ECFFEBE10</gtr:id><gtr:impact>1 review published:
http://vir.sgmjournals.org/content/95/Pt_3/517.full.pdf
More publications are planned.</gtr:impact><gtr:outcomeId>sTfLuxCVrY8-1</gtr:outcomeId><gtr:partnerContribution>We interact on several the work packages, and CVR/Kohl leads one of the work packages.</gtr:partnerContribution><gtr:piContribution>Kohl leads the the RiftVectors consortium, which studies the vectors of Rift Valley fever. This includes partners in the UK, France and Italy. subcontractors are located in Italy and Senegal. Associated partners of the RiftVectors consortium are based in Germany and the UK.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Print Media Engagment- Ebola Crisis</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C5C137E3-9C70-4971-81C6-033B4671F1F1</gtr:id><gtr:impact>Interaction with press (several national daily newspapers); interpretation of information during the Ebola outbreak.

Increased public understanding of UK preparedness to Ebola and the biology of the disease. Impact is difficult to measure but newspapers with wide circulation and online presence reach a large audience.

I indicate one URL below; I was quoted elsewhere too and the CVR communications office have more on these activities.</gtr:impact><gtr:outcomeId>545218a84ebd59.06291869</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.telegraph.co.uk/science/science-news/11072505/Ebola-outbreak-William-Pooleys-mum-glad-passport-has-been-incinerated.html</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Media Centre Ebola Media Commentary: Dr Alain Kohl September 2014 - January 2015</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F2FBF44D-7560-404A-8B1B-83B5252C9C11</gtr:id><gtr:impact>Dr Alain Kohl has been asked to provide comments on several occasions since the start of the Ebola outbreak. The Science Media Centre provided a round up of comments provided to the National media in January 2015.

Since providing initial comments since the start of the outbreak, Dr Alain Kohl has been interviewed and asked for comments on several occasions. His comments have been included in an article in the Daily Telegraph to name but a few. Dr Kohl was subsequently asked to be interviewed to discuss the Ebola outbreak by BBC radio Scotland and also BBC Radio 5 Live. The following are links to articles where Dr Kohl's comments have been featured:

http://www.dailymail.co.uk/wires/pa/article-2737846/Hopes-raised-Ebola-breakthrough.html
http://www.dailymail.co.uk/health/article-2737912/Ebola-drug-Zmapp-100-effective-treating-monkeys-deadly-disease-scientists-declare.html
http://www.heraldscotland.com/mobile/news/health/hopes-for-ebola-cure-as-tests-on-monkeys-successful.25177748
http://www.telegraph.co.uk/health/healthnews/11056384/Ebola-victim-William-Pooley-doing-fine-and-expects-to-recover-in-fortnight.html</gtr:impact><gtr:outcomeId>552ba18f4da568.81955943</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Radio 5 Live - Dr Alain Kohl Interview January 2015</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>BCD03AC3-917E-43A5-9D1B-56F286EF994A</gtr:id><gtr:impact>This interview came at a crucial time, coinciding with the news that a healthcare worker from Scotland had become infected with Ebola while volunteering in Sierra Leone. This was a high profile news incident and provided the CVR with an opportunity to respond and contribute expert opinion while reaching a varied audience.

None to report at present but it is anticipated that any further incidents related to the Ebola outbreak (or other high profile incidents related to virus research) could result in further requests for interviews and comments.</gtr:impact><gtr:outcomeId>550ac20dcb1268.58546791</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/programmes/b04vjbvc</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media interactions Zika virus outbreak</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AEF01946-0BBD-49E6-A077-72E047EEB21A</gtr:id><gtr:impact>Numerous interviews for print media (including NY Times, Spiegel) and blogs.</gtr:impact><gtr:outcomeId>56bf80b18ed254.88411218</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Chikungunya Press Release - September 2014 - Dr Alain Kohl</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7B2721D0-144A-422E-9439-4B52044AAEC9</gtr:id><gtr:impact>Dr Alain Kohl worked with the University of Glasgow's Corporate Communications team to produce a press release related to his research in the area of Chikungunya Virus, which is an area of international media interest. The press release was circulated to both National and appropriate International media channels and share on the University news page on the website.

The press release was picked up by a wide range of International publications. Cuttings as follows:

http://www.nla-eclips.com/PDFs/BRA363B.PDF
http://www.healthcanal.com/infections/54782-glasgow-led-research-group-identifies-potential-pathway-for-blocking-transmission-of-chikungunya-virus.html
http://www.medicina21.com/Notas_De_Prensa/V7969-Glasgow-led_research_group_identifies_potential_pathway_for_blocking_transmission_of_Chikungunya_virus.html
http://investing.businessweek.com/research/markets/news/article.asp?docKey=600-201409030715M2______EUPR_____ade000000434bdb6_3600-1
http://www.voyagerluxe.com/Chikungunya-une-piste-pour-un-remede-contre_le-virus.5386.html
http://www.farmanews.com/notas_de_prensa/V7969-Glasgow-led_research_group_identifies_potential_pathway_for_blocking_transmission_of_Chikungunya_virus.html
http://indianexpress.com/article/technology/science/potential-pathway-to-block-chikungunya-virus-identified/
http://www.business-standard.com/article/pti-stories/potential-pathway-to-block-chikungunya-virus-identified-114090300905_1.html
http://www.modernghana.com/news/567298/1/glasgow-led-research-group-identifies-potential-pa.html</gtr:impact><gtr:outcomeId>552ba9ac088ea6.04710812</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.gla.ac.uk/news/headline_357314_en.html</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dr Alain Kohl BBC News Interview October 2012</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EADF0D53-2FC7-42DC-BA25-189E4EBAA1E5</gtr:id><gtr:impact>Following the death of a patient infected by Crimean-Congo Viral Haemorrhagic Fever in a hospital in Glasgow, Dr Alain Kohl was interviewed by the BBC Scotland News reporters and featured on the evening news during two time slots. Dr Kohl provided an expert opinion on the situation for the information of the media and the public.

This was a rapid response to a high profile media case and highlighted the world class research that the CVR carries out in Glasgow. This was an opportunity to inform the public and alleviate concerns around risk related to the spread of the infectious disease.</gtr:impact><gtr:outcomeId>55268548c39c57.75787269</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>https://www.facebook.com/centreforvirusresearch</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media interactions Zika virus outbreak</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B7E5AF75-1972-41B0-BED7-380051E1E569</gtr:id><gtr:impact>TV interviews for BBC (News and World), ITV.</gtr:impact><gtr:outcomeId>56bf81a40ca680.09599028</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CVR Facebook page</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B3CDC9C3-75BB-44C7-9C40-CCC757E46C91</gtr:id><gtr:impact>The CVR facebook page allows us to explain select, virology-related news as well as CVR activity to the public.

It is at present too early to assess the impact of this communication channel.</gtr:impact><gtr:outcomeId>Bd9DaDxogVS</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Chikungunya Article: The Guardian - Dr Alain Kohl Nov 2014</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7D92795B-9B22-4635-A07E-A6EBCB73B403</gtr:id><gtr:impact>Dr Alain Kohl was asked for comments in relation to an article the Guardian were intending to run about Chikungunya virus. Dr Kohl was featured in the article in the high profile newspaper, which has a circulation figure of 187,000 annual daily sales plus an online website presence.

Dr Kohl was subsequently asked to make comment by the Science Media Centre for supply to the National media.</gtr:impact><gtr:outcomeId>552ba849e63620.22074526</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.theguardian.com/global-development/2014/nov/24/chikungunya-ebola-south-america-epidemic-virus</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>378259</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMIDA-ERA</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/K001140/1</gtr:fundingRef><gtr:id>01914DA7-8DFC-4B5B-ABBA-A2430252629E</gtr:id><gtr:outcomeId>g4TGygnQmzB</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1050000</gtr:amountPounds><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:currCode>SEK</gtr:currCode><gtr:currCountryCode>Sweden</gtr:currCountryCode><gtr:currLang>sv_SE</gtr:currLang><gtr:description>International Postdoc (Internationell Postdok)</gtr:description><gtr:end>2015-02-02</gtr:end><gtr:fundingOrg>Swedish Research Council</gtr:fundingOrg><gtr:id>20616D41-41F2-49E6-91D5-57CF379F6DF6</gtr:id><gtr:outcomeId>56c1d674c38cb8.83066454</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>195454</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Horizon 2020</gtr:department><gtr:description>Horizon 2020 MSCA Fellowship Margus Varjak</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>661232 - MAPP</gtr:fundingRef><gtr:id>6E8C9020-63E4-45E2-819A-5A23C954899E</gtr:id><gtr:outcomeId>56bf7d27483cf2.62833775</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Horizon 2020 Zikalliance</gtr:description><gtr:end>2020-01-02</gtr:end><gtr:fundingOrg>European Union</gtr:fundingOrg><gtr:id>B5194664-E078-4BCB-A3B2-75DB5057D776</gtr:id><gtr:outcomeId>5899fd6f0a8357.19971130</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>36000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Wellcome Trust Zika Rapid Response</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MC_PC_15105</gtr:fundingRef><gtr:id>D0F66249-406C-4669-A9E5-F14BAEAF0306</gtr:id><gtr:outcomeId>5899ff4da47f16.13938947</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>55000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Medical Research Foundation</gtr:department><gtr:description>Equipment Grant</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>0CB022F5-AF87-40BE-8BF7-065C04BB8FE7</gtr:id><gtr:outcomeId>54523e15b42ac9.09970733</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>221947</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UK-Brazil Neglected Infectious Diseases Partnership, MRC-Confap Newton Fund</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/N017552/1</gtr:fundingRef><gtr:id>9CF75BCD-4CFC-4E45-9464-C7F28C831271</gtr:id><gtr:outcomeId>56bf7b1bc75416.31925691</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>32000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Wellcome Trust Zika Rapid Response</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MC_PC_15081</gtr:fundingRef><gtr:id>10DC54DE-6F76-45CD-A6A4-63CD9F5A3592</gtr:id><gtr:outcomeId>5899ffd76f7598.13121898</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BBSRC Vector-Borne Diseases Expert Working Group</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>30521535-18F5-44CB-B05F-90E8EFB000C7</gtr:id><gtr:outcomeId>54522db02444d0.14666908</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>pre-SAGE UK Government Advisory Group: Zika virus outbreak</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BA27602B-571D-4AA3-89C5-8B0FD31E169F</gtr:id><gtr:outcomeId>589a06acc36f75.49560130</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>House Commons, Science and Technology Committee Witness</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>067E9043-A275-41B3-A10F-FDF299A796EE</gtr:id><gtr:outcomeId>56bf826e6964d5.72970922</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Antibodies to Zika virus E protein.</gtr:description><gtr:id>0C7872C5-CCCA-47E6-8E25-7A8D0A017A27</gtr:id><gtr:impact>None yet; currently assessed.</gtr:impact><gtr:outcomeId>5899f468ebb860.86446544</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Antibody to Zika virus E protein</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A reverse genetics system that allows to manipulate the Schmallenberg virus genome. This is based on cDNA clones for the three viral genome segments.</gtr:description><gtr:id>EF5CD82A-9506-4E7D-B9B2-9904E7E04605</gtr:id><gtr:impact>This can be used for vaccine development, development of viral vectors etc.</gtr:impact><gtr:outcomeId>ofdh5uKxzxX</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Schmallenberg virus reverse genetics system</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.1003133</gtr:url></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>Software to analyse small RNAs</gtr:description><gtr:id>DC73F060-D0F5-431A-BBF9-FED9DE7B9BCE</gtr:id><gtr:impact>Not known in detail; personal comments from other researchers suggest software was well received.</gtr:impact><gtr:outcomeId>56bf83cdbf49f9.96803081</gtr:outcomeId><gtr:title>viRome Small RNA Analysis Software</gtr:title><gtr:type>Webtool/Application</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/23709497</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>671D8F86-3077-4C3F-A0B3-E9792EFBF7C7</gtr:id><gtr:title>Differential effects of lipid biosynthesis inhibitors on Zika and Semliki Forest viruses.</gtr:title><gtr:parentPublicationTitle>Veterinary journal (London, England : 1997)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3cd2a644680f2a250e4eb45e3ad2364"><gtr:id>d3cd2a644680f2a250e4eb45e3ad2364</gtr:id><gtr:otherNames>Royle J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1090-0233</gtr:issn><gtr:outcomeId>5a2fda59e204c1.14048908</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF243D58-37FC-4F3B-8311-319B968356EF</gtr:id><gtr:title>Culex quinquefasciatus mosquitoes do not support replication of Zika virus.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40b7b4698587df85235f29b017b56168"><gtr:id>40b7b4698587df85235f29b017b56168</gtr:id><gtr:otherNames>Louren?o-de-Oliveira R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>5a661a415f7432.64593747</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2396B4F-A899-4309-B1F5-DC476FE839A6</gtr:id><gtr:title>The Importance of Socio-Economic Versus Environmental Risk Factors for Reported Dengue Cases in Java, Indonesia.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/599301bc7cff9b4aec6428b1e01c4384"><gtr:id>599301bc7cff9b4aec6428b1e01c4384</gtr:id><gtr:otherNames>Wijayanti SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>589a0471749a03.44865325</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2DC3E6E-3071-4CFB-9B86-93A89FBBD09E</gtr:id><gtr:title>The Antiviral RNAi Response in Vector and Non-vector Cells against Orthobunyaviruses.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f25e8a22839c8eaf9492900e3ab52a36"><gtr:id>f25e8a22839c8eaf9492900e3ab52a36</gtr:id><gtr:otherNames>Dietrich I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>588b63888a9727.26867334</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4971CAA-777B-4C9C-AAAC-460A007201BE</gtr:id><gtr:title>Zika virus tropism and interactions in myelinating neural cell cultures: CNS cells and myelin are preferentially affected.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60c30f874eadc852e45f04ddbcffffca"><gtr:id>60c30f874eadc852e45f04ddbcffffca</gtr:id><gtr:otherNames>Cumberworth SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>5a6614a3b9ca73.01012190</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C566D433-29CC-4F0F-8BDE-B0EC3C90A312</gtr:id><gtr:title>Bunyavirus requirement for endosomal K+ reveals new roles of cellular ion channels during infection.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/926c0fcc0df3d08f59385abe30c3d733"><gtr:id>926c0fcc0df3d08f59385abe30c3d733</gtr:id><gtr:otherNames>Hover S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5a8c1ff5444221.07638704</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC111985-CB69-4564-970E-9B6EDA473AA4</gtr:id><gtr:title>Mitigating the risk of Zika virus contamination of raw materials and cell lines in the manufacture of biologicals.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f8c4d5890e1b854bb196451fc8e7876"><gtr:id>9f8c4d5890e1b854bb196451fc8e7876</gtr:id><gtr:otherNames>Zmurko J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>5a66193a93bd76.44999063</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C546B9D-6BDF-4D61-9735-BAE2F617B5DD</gtr:id><gtr:title>Dengue in Java, Indonesia: Relevance of Mosquito Indices as Risk Predictors.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/599301bc7cff9b4aec6428b1e01c4384"><gtr:id>599301bc7cff9b4aec6428b1e01c4384</gtr:id><gtr:otherNames>Wijayanti SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>589a04723753b7.05775968</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33AB66D7-3CAF-40CA-A932-DF7906D5F7A2</gtr:id><gtr:title>Piwi4 Is a Noncanonical PIWI Protein Involved in Antiviral Responses.</gtr:title><gtr:parentPublicationTitle>mSphere</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4efe7f31d38842a9b99722017a1ac260"><gtr:id>4efe7f31d38842a9b99722017a1ac260</gtr:id><gtr:otherNames>Varjak M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2379-5042</gtr:issn><gtr:outcomeId>5a703da2cb8008.68358554</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7407839-35AC-4F97-ADE5-0C50060B37F7</gtr:id><gtr:title>Host Inflammatory Response to Mosquito Bites Enhances the Severity of Arbovirus Infection.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d33e1c1a77e61ed121d673cf9d7c59ff"><gtr:id>d33e1c1a77e61ed121d673cf9d7c59ff</gtr:id><gtr:otherNames>Pingen M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>589a04719cd5d8.14343394</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C07F7F6F-B526-4CC0-AB30-356A00FB7089</gtr:id><gtr:title>RNA Interference Restricts Rift Valley Fever Virus in Multiple Insect Systems.</gtr:title><gtr:parentPublicationTitle>mSphere</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f25e8a22839c8eaf9492900e3ab52a36"><gtr:id>f25e8a22839c8eaf9492900e3ab52a36</gtr:id><gtr:otherNames>Dietrich I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2379-5042</gtr:issn><gtr:outcomeId>5a66151f8219f8.79673589</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>937F7FF7-EFD9-4CEF-A690-D8B65B9D1A1E</gtr:id><gtr:title>Mutational analysis of Rift Valley fever phlebovirus nucleocapsid protein indicates novel conserved, functional amino acids.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9abf3004f1aa7ae73a4f05ee5ab4d0ce"><gtr:id>9abf3004f1aa7ae73a4f05ee5ab4d0ce</gtr:id><gtr:otherNames>Mottram TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>5a8c1fac6c0c55.86696198</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5876A822-8232-4868-979B-061B38E8B19D</gtr:id><gtr:title>Modulation of Potassium Channels Inhibits Bunyavirus Infection.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/926c0fcc0df3d08f59385abe30c3d733"><gtr:id>926c0fcc0df3d08f59385abe30c3d733</gtr:id><gtr:otherNames>Hover S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>56bf66ae972725.67047315</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>495380B3-7CAB-4E85-9F17-60DA0A4A6976</gtr:id><gtr:title>Inhibition of type I interferon induction and signalling by mosquito-borne flaviviruses.</gtr:title><gtr:parentPublicationTitle>Cellular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60c30f874eadc852e45f04ddbcffffca"><gtr:id>60c30f874eadc852e45f04ddbcffffca</gtr:id><gtr:otherNames>Cumberworth SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1462-5814</gtr:issn><gtr:outcomeId>5a66131bbfe346.60507341</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4593A18F-2C13-4274-817C-EC34EEB06B54</gtr:id><gtr:title>Advancing vector biology research: a community survey for future directions, research applications and infrastructure requirements.</gtr:title><gtr:parentPublicationTitle>Pathogens and global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51b808d9776f82850abc4aa3d4bd00b1"><gtr:id>51b808d9776f82850abc4aa3d4bd00b1</gtr:id><gtr:otherNames>Kohl A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2047-7724</gtr:issn><gtr:outcomeId>585d4812e3cbf4.24945292</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>680398A9-4AE7-44FD-80C5-3079000FB8E9</gtr:id><gtr:title>Wolbachia restricts insect-specific flavivirus infection in Aedes aegypti cells.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b89354079a660811744cb1a251293992"><gtr:id>b89354079a660811744cb1a251293992</gtr:id><gtr:otherNames>Schnettler E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>5899ed8fddd1a1.67530401</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C96F170-6A14-40F0-9D24-CA1BEC059BE2</gtr:id><gtr:title>Analysis of tick-borne encephalitis virus-induced host responses in human cells of neuronal origin and interferon-mediated protection.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ace78483606d075289cf25f52efa015d"><gtr:id>ace78483606d075289cf25f52efa015d</gtr:id><gtr:otherNames>Selinger M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>5a8c1eab630772.90960250</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E92773E2-391E-406C-83BD-5E30CF9E65AD</gtr:id><gtr:title>Vector competence of Aedes vexans (Meigen), Culex poicilipes (Theobald) and Cx. quinquefasciatus Say from Senegal for West and East African lineages of Rift Valley fever virus.</gtr:title><gtr:parentPublicationTitle>Parasites &amp; vectors</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7a5285c83ff4ccc3449347fafe8a0f1"><gtr:id>e7a5285c83ff4ccc3449347fafe8a0f1</gtr:id><gtr:otherNames>Ndiaye el H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1756-3305</gtr:issn><gtr:outcomeId>585d52df61ae76.73065425</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16BA1C46-054C-4417-8122-D5A32A882C7F</gtr:id><gtr:title>Zika virus: a previously slow pandemic spreads rapidly through the Americas.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12c2867c4bfff5cf6a064e8024a410c5"><gtr:id>12c2867c4bfff5cf6a064e8024a410c5</gtr:id><gtr:otherNames>Gatherer D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>56bf64e1532db9.04694901</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A311EF4E-01A7-4CFE-AB4B-D296E0D9C16C</gtr:id><gtr:title>Wolbachia Blocks Viral Genome Replication Early in Infection without a Transcriptional Response by the Endosymbiont or Host Small RNA Pathways.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b383a4a3af9aa61b027350a68273413f"><gtr:id>b383a4a3af9aa61b027350a68273413f</gtr:id><gtr:otherNames>Rainey SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>585d47a03a33f7.68055346</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B16C3395-E7E3-4496-B48D-03AAEF81498A</gtr:id><gtr:title>Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa671f4dc2624aa5386c142ed2596a4e"><gtr:id>aa671f4dc2624aa5386c142ed2596a4e</gtr:id><gtr:otherNames>Burt FJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>589a0471477694.20926235</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CB7DEB1-A5AB-4A4A-A2BC-CA81E242489C</gtr:id><gtr:title>Full Genome Sequence and sfRNA Interferon Antagonist Activity of Zika Virus from Recife, Brazil.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8f028a0beb9437345f8ec909e45a6cb"><gtr:id>e8f028a0beb9437345f8ec909e45a6cb</gtr:id><gtr:otherNames>Donald CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>585d3e3ed58920.10868314</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EC73702-0543-4C4C-A940-5D7259D6D717</gtr:id><gtr:title>Spindle-E Acts Antivirally Against Alphaviruses in Mosquito Cells.</gtr:title><gtr:parentPublicationTitle>Viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4efe7f31d38842a9b99722017a1ac260"><gtr:id>4efe7f31d38842a9b99722017a1ac260</gtr:id><gtr:otherNames>Varjak M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1999-4915</gtr:issn><gtr:outcomeId>5a942aa1e41b23.03582476</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>804D5919-1718-4D9C-AD5E-E85007839385</gtr:id><gtr:title>Characterization of the Zika virus induced small RNA response in Aedes aegypti cells.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4efe7f31d38842a9b99722017a1ac260"><gtr:id>4efe7f31d38842a9b99722017a1ac260</gtr:id><gtr:otherNames>Varjak M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>5a8c1f4a6eb8a1.93266064</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UU_12014/8</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>